rtki cpd has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belenfant, X; Bollée, G; Boucheix, C; Callard, P; Casal, I; Dussaule, JC; Endlich, K; Endlich, N; Flamant, M; Fligny, C; Galaup, A; Germain, S; Kopp, JB; Mesnard, L; Milon, M; Quaggin, SE; Rodenas, A; Rumpel, E; Sabaa, N; Salant, DJ; Schordan, E; Schordan, S; Sunnarborg, SW; Tharaux, PL; Threadgill, DW; Vandermeersch, S | 1 |
1 other study(ies) available for rtki cpd and Bright Disease
| Article | Year |
|---|---|
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.
Topics: Analysis of Variance; Animals; Blotting, Western; Bone Marrow Transplantation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Flow Cytometry; Glomerulonephritis; Heparin-binding EGF-like Growth Factor; Humans; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Kidney Glomerulus; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Phosphorylation; Podocytes; Quinazolines; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Statistics, Nonparametric; Tyrphostins | 2011 |